Abstract
This study aimed to investigate the effect of doxorubicin co-treatment with taurine on B16F10 melanoma cells. Frequently, Doxorubicin is used in the treatments of many different kinds of cancers, some of which are soft tissue sarcomas, hematological malignancies and carcinomas. However, the clinical application of doxorubicin is compromised by its severe adverse effects, including cardiotoxicity. In the present study, the efficacy of doxorubicin co-treatment with taurine was investigated. B16F10 cell viability was evaluated using MTT assays, trypan blue dye exclusion assays, and fluorescent staining technique. Apoptotic cells were detected by flow cytometry and the proteins associated with apoptosis and cellular differentiations were assessed by immunoblotting. Doxorubicin inhibited cell growth and induced cell death in B16F10 cells. Interestingly, doxorubicin co-treatment with taurine inhibited apoptosis in B16F10 cells. These results indicate that doxorubicin co-treatment with taurine attenuates doxorubicin-induced cytotoxicity and reduces ROS production in B16F10 cells.
$These authors contributed equally to this work.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdih H, Kelly CJ, Bouchier-Hayes D, Barry M, Kearns S (2000) Taurine prevents interleukin-2-induced acute lung injury in rats. Eur Surg Res 32:347–352
Awasthi S, Sharma R, Singhal SS, Zimniak P, Awasthi YC (2002) RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metab Dispos 30:1300–1310
Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15:7–10
Condron C, Casey RG, Kehoe S, Toomey D, Creagh T, Bouchier-Hayes DJ (2010) Taurine modulates neutrophil function but potentiates uropathogenic E. coli infection in the murine bladder. Urol Res 38:215–222
Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ, Hsu CC, Faiman MD, Schloss JV, Wu JY (2001) Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J Neurosci Res 66:612–619
Chen XC, Pan ZL, Liu DS, Han X (1998) Effect of taurine on human fetal neuron cells: proliferation and differentiation. Adv Exp Med Biol 442:397–403
Das J, Ghosh J, Manna P, Sil PC (2011) Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem Pharmacol 81:891–909
Godfrey DA, Farms WB, Godfrey TG, Mikesell NL, Liu J (2000) Amino acid concentrations in rat cochlear nucleus and superior olive. Hearing Res 150:189–205
Gordon RE, Park E, Laskin D, Schuller-Levis GB (1998) Taurine protects rat bronchioles from acute ozone exposure: a freeze fracture and electron microscopic study. Exp Lung Res 24:659–674
Gurujeyalakshmi G, Wang Y, Giri SN (2000) Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-κB in mice. J Pharm Exp Therap 293:82–90
Haq MM, Legha SS, Choksi J, Hortobagyi GN, Benjamin RS, Ewer M, Ali M (1985) Doxorubicin-induced congestive heart failure in adults. Cancer 56:1361–1365
Harada H, Tsujino T, Watari Y, Nonaka H, Emoto N, Yokoyama M (2004) Oral taurine supplementation prevents fructose-induced hypertension in rats. Heart Vessels 19:132–136
Hanna J, Chahine R, Aftimos G, Nader M, Mounayar A, Esseily F, Chamat S (2004) Protective effect of taurine against free radicals damage in the rat myocardium. Exp Toxicol Path 56:189–194
Haunstetter A, Izumo S (1998) Apoptosis basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111–1129
Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang SF, Chiang WL, Chu SC (2007) The tumor-growth inhibitory activity of flavanone and 2′-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. J Biomed Sci 14:107–119
Hsu TC, Chiang SY, Wu JH, Tsai CC, Huang CY, Chen YC, Tzang BS (2008) Treatment with taurine attenuates hepatic apoptosis in NZB/W F1 mice fed with a high-cholesterol diet. J Agr Food Chem 56:9685–9691
Iliskovic N, Singal PK (1997) Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol 150:727–734
Jeon SH, Lee MY, Rahman MM, Kim SJ, Kim GB, Park SY, Hong CU, Kim SZ, Kim JS, Kang HS (2009) The antioxidant, taurine reduced lipopolysaccharide (LPS)-induced generation of ROS, and activation of MAPKs and Bax in cultured pneumocytes. Pulm Pharmacol Ther 22:562–566
Jin Y, Kim HP, Chi M, Ifedigbo E, Ryter SW, Choi AM (2008) Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am J Resp Cell Mol 39:171–179
Kontny E, Szczepańska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, Maśliński W (2000) The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43:2169–2177
Marcinkiewicz J (2009) Taurine bromamine: a new therapeutic option in inflammatory skin diseases. Pol Arch Med Wewn 119:673–676
Nakajima Y, Osuka K, Seki Y, Gupta RC, Hara M, Takayasu M, Wakabayashi T (2010) Taurine reduces inflammatory responses after spinal cord injury. J Neurotraum 27:403–410
Racasan S, Braam B, van der Giezen DM, Goldschmeding R, Boer P, Koomans HA, Joles JA (2004) Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 44:83–88
Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219–236
Redmond HP, Wang JH, Bouchier-Hayes D (1996) Taurine attenuates nitric oxide-and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 131:1280–1288
Ribeiro RA, Vanzela EC, Oliveira CA, Bonfleur ML, Boschero AC, Carneiro EM (2010) Taurine supplementation: involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2+ handling in mouse pancreatic islets. Brit J Nutr 104:1148–1155
Rudolfová P, HanuÅ¡ová V, Skálová L, BártÃková H, MatouÅ¡ková P, BouÅ¡ová I (2014) Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro. Acta Pharmaceut 64:199–209
Shan K, Lincoff AM, Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47–58
Sochor J, Nejdl L, Ruttkay-Nedecky B, Bezdekova A, Lukesova K, Zitka O, Cernei N, Mares P, Pohanka M, Adama V, Babula P, Beklova M, Zeman L, Kizek R (2014) Investigating the influence of taurine on thiol antioxidant status in Wistar rats with a multi-analytical approach. J Appl Biomed 12:97–110
Stapleton PP, O'Flaherty L, Redmond HP, Bouchier-Hayes DJ (1998) Review: host defense-a role for the amino acid taurine? J Parenteral Enteral Nutr 22:42–48
Sun M, Zhao Y, Gu Y, Xu C (2012) Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. Amino Acids 42:1735–1747
Timbrell JA, Seabra V, Waterfield CJ (1995) The in vivo and in vitro protective properties of taurine. Gen Pharmacol: Vascular Syst 26:453–462
Ueki I, Stipanuk MH (2009) 3T3-L1 adipocytes and rat adipose tissue have a high capacity for taurine synthesis by the cysteine dioxygenase/cysteine sulfinate decarboxylase and cysteamine dioxygenase pathways. J Nutr 139:207–214
Venkatachalam S, Kuppusamy P, Kuppusamy B, Dhanapal S (2014) The potency of essential nutrient taurine on boosting the antioxidant status and chemopreventive effect against benzo (a) pyrene induced experimental lung cancer. Biomed Prev Nutr 4:251–255
Zhang F, Mao Y, Qiao H, Jiang H, Zhao H, Chen X, Tong L, Sun X (2010) Protective effects of taurine against endotoxin-induced acute liver injury after hepatic ischemia reperfusion. Amino Acids 38:237–245
Acknowledgements
This work was supported by a special grant from Konkuk University in 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this paper
Cite this paper
Kim, YS. et al. (2017). Taurine Attenuates Doxorubicin-Induced Toxicity on B16F10 Cells. In: Lee, DH., Schaffer, S.W., Park, E., Kim, H.W. (eds) Taurine 10. Advances in Experimental Medicine and Biology, vol 975. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1079-2_94
Download citation
DOI: https://doi.org/10.1007/978-94-024-1079-2_94
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1077-8
Online ISBN: 978-94-024-1079-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)